Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Theor Appl Genet ; 137(3): 54, 2024 Feb 21.
Article in English | MEDLINE | ID: mdl-38381205

ABSTRACT

KEY MESSAGE: Integrated phenomics, ionomics, genomics, transcriptomics, and functional analyses present novel insights into the role of pectin demethylation-mediated cell wall Na+ retention in positively regulating salt tolerance in oilseed rape. Genetic variations in salt stress tolerance identified in rapeseed genotypes highlight the complicated regulatory mechanisms. Westar is ubiquitously used as a transgenic receptor cultivar, while ZS11 is widely grown as a high-production and good-quality cultivar. In this study, Westar was found to outperform ZS11 under salt stress. Through cell component isolation, non-invasive micro-test, X-ray energy spectrum analysis, and ionomic profile characterization, pectin demethylation-mediated cell wall Na+ retention was proposed to be a major regulator responsible for differential salt tolerance between Westar and ZS11. Integrated analyses of genome-wide DNA variations, differential expression profiling, and gene co-expression networks identified BnaC9.PME47, encoding a pectin methylesterase, as a positive regulator conferring salt tolerance in rapeseed. BnaC9.PME47, located in two reported QTL regions for salt tolerance, was strongly induced by salt stress and localized on the cell wall. Natural variation of the promoter regions conferred higher expression of BnaC9.PME47 in Westar than in several salt-sensitive rapeseed genotypes. Loss of function of AtPME47 resulted in the hypersensitivity of Arabidopsis plants to salt stress. The integrated multiomics analyses revealed novel insights into pectin demethylation-mediated cell wall Na+ retention in regulating differential salt tolerance in allotetraploid rapeseed genotypes. Furthermore, these analyses have provided key information regarding the rapid dissection of quantitative trait genes responsible for nutrient stress tolerance in plant species with complex genomes.


Subject(s)
Arabidopsis , Brassica napus , Brassica rapa , Salt Tolerance/genetics , Brassica napus/genetics , Pectins , Salt Stress , Cell Wall , Demethylation
2.
Commun Biol ; 6(1): 1297, 2023 12 21.
Article in English | MEDLINE | ID: mdl-38129517

ABSTRACT

N6-methyladenosine (m6A) plays a crucial role in the development and functional homeostasis of the central nervous system. The fat mass and obesity-associated (FTO) gene, which is highly expressed in the hypothalamus, is closely related to female pubertal development. In this study, we found that m6A methylation decreased in the hypothalamus gradually with puberty and decreased in female rats with precocious puberty. FTO expression was increased at the same time. Methylated RNA immunoprecipitation sequencing (MeRIP-seq) showed that the m6A methylation of PLCß3, a key enzyme of the Ca2+ signalling pathway, was decreased significantly in the hypothalamus in precocious rats. Upregulating FTO increased PLCß3 expression and activated the Ca2+ signalling pathway, which promoted GnRH expression. Dual-luciferase reporter and MeRIP-qPCR assays confirmed that FTO regulated m6A demethylation of PLCß3 and promoted PLCß3 expression. Upon overexpressing FTO in the hypothalamic arcuate nucleus (ARC) in female rats, we observed advanced puberty onset. Meanwhile, PLCß3 and GnRH expression in the hypothalamus increased significantly, and the Ca2+ signalling pathway was activated. Our study demonstrates that FTO enhances GnRH expression, which promotes puberty onset, by regulating m6A demethylation of PLCß3 and activating the Ca2+ signalling pathway.


Subject(s)
Hypothalamus , Signal Transduction , Animals , Female , Rats , Demethylation , Gonadotropin-Releasing Hormone/genetics , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/metabolism , Methylation
3.
Mol Biol Rep ; 50(9): 7783-7796, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37480509

ABSTRACT

DNA methylation and demethylation are widely acknowledged epigenetic phenomena which can cause heritable and phenotypic changes in functional genes without changing the DNA sequence. They can thus affect phenotype formation in medicinal plants. However, a comprehensive review of the literature summarizing current research trends in this field is lacking. Thus, this review aims to provide an up-to-date summary of current methods for the detection of 5-mC DNA methylation, identification and analysis of DNA methyltransferases and demethyltransferases, and regulation of DNA methylation in medicinal plants. The data showed that polyploidy and environmental changes can affect DNA methylation levels in medicinal plants. Changes in DNA methylation can thus regulate plant morphogenesis, growth and development, and formation of secondary metabolites. Future research is required to explore the mechanisms by which DNA methylation regulates the accumulation of secondary metabolites in medicinal plants.


Subject(s)
Plants, Medicinal , Plants, Medicinal/genetics , DNA Methylation/genetics , DNA Modification Methylases , Epigenomics , Demethylation
4.
Mitochondrion ; 72: 22-32, 2023 09.
Article in English | MEDLINE | ID: mdl-37451354

ABSTRACT

Mitochondrial functions play a crucial role in determining the metabolic and thermogenic status of brown adipocytes. Increasing evidence reveals that the mitochondrial oxidative phosphorylation (OXPHOS) system plays an important role in brown adipogenesis, but the mechanistic insights are limited. Herein, we explored the potential metabolic mechanisms leading to OXPHOS regulation of brown adipogenesis in pharmacological and genetic models of mitochondrial respiratory complex I deficiency. OXPHOS deficiency inhibits brown adipogenesis through disruption of the brown adipogenic transcription circuit without affecting ATP levels. Neither blockage of calcium signaling nor antioxidant treatment can rescue the suppressed brown adipogenesis. Metabolomics analysis revealed a decrease in levels of tricarboxylic acid cycle intermediates and heme. Heme supplementation specifically enhances respiratory complex I activity without affecting complex II and partially reverses the inhibited brown adipogenesis by OXPHOS deficiency. Moreover, the regulation of brown adipogenesis by the OXPHOS-heme axis may be due to the suppressed histone methylation status by increasing histone demethylation. In summary, our findings identified a heme-sensing retrograde signaling pathway that connects mitochondrial OXPHOS to the regulation of brown adipocyte differentiation and metabolic functions.


Subject(s)
Adipogenesis , Histones , Adipogenesis/genetics , Histones/metabolism , Electron Transport Complex I/metabolism , Demethylation , Cell Differentiation
5.
CNS Neurosci Ther ; 29(11): 3479-3492, 2023 11.
Article in English | MEDLINE | ID: mdl-37287407

ABSTRACT

AIMS: Lysine-specific demethylase 6B (KDM6B) serves as a key mediator of gene transcription. It regulates expression of proinflammatory cytokines and chemokines in variety of diseases. Herein, the role and the underlying mechanisms of KDM6B in inflammatory pain were studied. METHODS: The inflammatory pain was conducted by intraplantar injection of complete Freund's adjuvant (CFA) in rats. Immunofluorescence, Western blotting, qRT-PCR, and chromatin immunoprecipitation (ChIP)-PCR were performed to investigate the underlying mechanisms. RESULTS: CFA injection led to upregulation of KDM6B and decrease in the level of H3K27me3 in the dorsal root ganglia (DRG) and spinal dorsal horn. The mechanical allodynia and thermal hyperalgesia following CFA were alleviated by the treatment of intrathecal injection of GSK-J4, and by microinjection of AAV-EGFP-KDM6B shRNA in the sciatic nerve or in lumbar 5 dorsal horn. The increased production of tumor necrosis factor-α (TNF-α) following CFA in the DRGs and dorsal horn was inhibited by these treatments. ChIP-PCR showed that CFA-induced increased binding of nuclear factor κB with TNF-α promoter was repressed by the treatment of microinjection of AAV-EGFP-KDM6B shRNA. CONCLUSIONS: These results suggest that upregulated KDM6B via facilitating TNF-α expression in the DRG and spinal dorsal horn aggravates inflammatory pain.


Subject(s)
Ganglia, Spinal , Histones , Spinal Cord Dorsal Horn , Tumor Necrosis Factor-alpha , Animals , Rats , Demethylation , Freund's Adjuvant/toxicity , Ganglia, Spinal/metabolism , Histones/metabolism , Hyperalgesia/metabolism , Lysine/metabolism , Pain/metabolism , Pain Measurement , Rats, Sprague-Dawley , RNA, Small Interfering/metabolism , Spinal Cord Dorsal Horn/metabolism , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation
6.
J Hazard Mater ; 442: 130001, 2023 01 15.
Article in English | MEDLINE | ID: mdl-36152543

ABSTRACT

Recalcitrant and toxicological membrane-making wastewater displays negative impacts on environment, and this is difficult to treat efficiently using conventional hydrolytic acidification. In this study, a novel electro-assisted biological reactor with micro-aerobic cathode (EABR-MAC) was developed to improve the biodegradation and ammonification of N, N-dimethylformamide (DMF) in membrane-making wastewater, and the metabolic mechanism using metagenomic sequencing as comprehensively illustrated. The results showed that EABR-MAC significantly improved the ammonification of refractory organonitrogen and promoted DMF oxidative degradation by driving the electron transferred to the cathode. Additionally, the inhibition rates of oxygen uptake rate and nitrification in EABR-MAC were both lower under different cathode aeration frequency conditions. Microbial community analysis indicated that the functional fermentation bacteria and exoelectrogens, which were correlated with COD removal, ammonification, and detoxification, were significantly enriched upon electrostimulation, and the positive biological connections increased to form highly connected communities instead of competition. The functional genes revealed that EABR-MAC forcefully intervened with the metabolic pathway, so that DMF converted to formamide and ammonia by oxidative demethylation and formamide hydrolysis. The results of this study provide a promising strategy for efficient conversion of organonitrogen into ammonia nitrogen, and offer a new insight into the effects of electrostimulation on microbial metabolism.


Subject(s)
Dimethylformamide , Wastewater , Ammonia/metabolism , Bioreactors , Nitrification , Nitrogen/metabolism , Electrodes , Oxygen , Demethylation , Denitrification
7.
J Hazard Mater ; 433: 128743, 2022 07 05.
Article in English | MEDLINE | ID: mdl-35366446

ABSTRACT

Upon environmental stimuli, aldehydes are generated downstream of reactive oxygen species and thereby contribute to severe cell damage. In this study, using two wheat genotypes differing in aluminum (Al) tolerance, we investigated the effects of lipid peroxidation-derived aldehydes on cell wall composition and subsequent Al-binding capacities. The spatial accumulation of Al along wheat roots was found to the generation of reactive aldehydes, which are highly localized to the apical regions of roots. Elimination of aldehydes by carnosine significantly reduced Al contents in root tips, with a concomitant alleviation of root growth inhibition. In contrast, root growth and Al accumulation were exacerbated by application of the short-chain aldehyde (E)-2-hexenal. We further confirmed that cell wall binding capacity, rather than malate efflux or pH alteration strategies, is associated with the aldehyde-induced accumulation of Al. Scavenging of lipid-derived aldehydes reduced Al accumulation in the pectin and hemicellulose 1 (HC1) fractions of root cell walls, whereas exposure to (E)-2-hexenal promoted a further accumulation of Al, particularly in the cell wall HC1 fraction of the Al-sensitive genotype. Different strategies were introduced by pectin and HC1 to accumulate Al in response to aldehydes in wheat roots. Accumulation in pectin is based on a reduction of methylation levels in response to elevated pectin methylesterase activity and gene expression, whereas that in HC1 is associated with an increase in polysaccharide contents. These findings indicate that aldehydes exacerbate Al phytotoxicity by enhancing Al retention in cell wall polysaccharides.


Subject(s)
Aluminum , Pectins , Aldehydes/metabolism , Aldehydes/toxicity , Aluminum/toxicity , Cell Wall/metabolism , Demethylation , Plant Roots/metabolism , Polysaccharides/metabolism , Seedlings , Triticum/metabolism
8.
Anticancer Res ; 42(2): 837-844, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35093881

ABSTRACT

BACKGROUND/AIM: Chemotherapy is used for recurrent and metastatic colorectal cancer, but the response rate of 5-fluorouracil (5-FU), the standard treatment for colorectal cancer, is low. We hypothesized that thymidine phosphorylase (TYMP) expression, a rate-limiting activating enzyme of 5-FU, is regulated by methylation of the gene promoter region, and demethylation of TYMP would increase sensitivity to 5-FU. MATERIALS AND METHODS: HCT116 colon cancer cells were treated with 5-aza-2'-deoxycytidine, a demethylating agent, and changes in TYMP transcription and sensitivity to 5-FU were evaluated. RESULTS: TYMP expression increased over 54-fold in HCT116 transfected with TYMP. The cytotoxicity of 5-FU increased up to 5.5-fold. In comparison, in HCT116 treated with 5-aza-2'-deoxycytidine, TYMP expression increased 5.8-fold. However, the cytotoxicity of 5-FU remained unchanged. CONCLUSION: Demethylating agent alone did not promote the cytotoxicity of 5-FU against colorectal cancer. To further increase the sensitivity to 5-FU, combination with adjuvant therapy focusing on metabolic pathways other than the TYMP pathway appear necessary.


Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Colorectal Neoplasms/drug therapy , Fluorouracil/pharmacology , Thymidine Phosphorylase/metabolism , Antimetabolites, Antineoplastic/therapeutic use , Cell Line, Tumor , Cell Survival/drug effects , Colorectal Neoplasms/metabolism , Decitabine/pharmacology , Demethylation , Drug Resistance, Neoplasm/drug effects , Fluorouracil/therapeutic use , Humans , Thymidine Phosphorylase/genetics , Transcription, Genetic
9.
Molecules ; 26(21)2021 Oct 20.
Article in English | MEDLINE | ID: mdl-34770760

ABSTRACT

Environmental stimuli attack the skin daily resulting in the generation of reactive oxygen species (ROS) and inflammation. One pathway that regulates oxidative stress in skin involves Protein Phosphatase 2A (PP2A), a phosphatase which has been previously linked to Alzheimer's Disease and aging. Oxidative stress decreases PP2A methylation in normal human dermal fibroblasts (NHDFs). Thus, we hypothesize agents that increase PP2A methylation and activity will promote skin health and combat aging. To discover novel inhibitors of PP2A demethylation activity, we screened a library of 32 natural botanical extracts. We discovered Grape Seed Extract (GSE), which has previously been reported to have several benefits for skin, to be the most potent PP2A demethylating extract. Via several fractionation and extraction steps we developed a novel grape seed extract called Activated Grape Seed Extract (AGSE), which is enriched for PP2A activating flavonoids that increase potency in preventing PP2A demethylation when compared to commercial GSE. We then determined that 1% AGSE and 1% commercial GSE exhibit distinct gene expression profiles when topically applied to a 3D human skin model. To begin to characterize AGSE's activity, we investigated its antioxidant potential and demonstrate it reduces ROS levels in NHDFs and cell-free assays equal to or better than Vitamin C and E. Moreover, AGSE shows anti-inflammatory properties, dose-dependently inhibiting UVA, UVB and chemical-induced inflammation. These results demonstrate AGSE is a novel, multi-functional extract that modulates methylation levels of PP2A and supports the hypothesis of PP2A as a master regulator for oxidative stress signaling and aging in skin.


Subject(s)
Flavonoids/pharmacology , Grape Seed Extract/pharmacology , Oxidative Stress/drug effects , Skin/drug effects , Skin/metabolism , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Antioxidants/chemistry , Antioxidants/pharmacology , Chemical Fractionation , Chromatography, High Pressure Liquid , Cytokines/biosynthesis , Demethylation/drug effects , Dose-Response Relationship, Drug , Fibroblasts/drug effects , Fibroblasts/metabolism , Flavonoids/chemistry , Flavonoids/isolation & purification , Grape Seed Extract/chemistry , Grape Seed Extract/isolation & purification , Humans , Protein Phosphatase 2/metabolism
10.
Nat Biotechnol ; 39(12): 1581-1588, 2021 12.
Article in English | MEDLINE | ID: mdl-34294912

ABSTRACT

RNA N6-methyladenosine (m6A) modifications are essential in plants. Here, we show that transgenic expression of the human RNA demethylase FTO in rice caused a more than threefold increase in grain yield under greenhouse conditions. In field trials, transgenic expression of FTO in rice and potato caused ~50% increases in yield and biomass. We demonstrate that the presence of FTO stimulates root meristem cell proliferation and tiller bud formation and promotes photosynthetic efficiency and drought tolerance but has no effect on mature cell size, shoot meristem cell proliferation, root diameter, plant height or ploidy. FTO mediates substantial m6A demethylation (around 7% of demethylation in poly(A) RNA and around 35% decrease of m6A in non-ribosomal nuclear RNA) in plant RNA, inducing chromatin openness and transcriptional activation. Therefore, modulation of plant RNA m6A methylation is a promising strategy to dramatically improve plant growth and crop yield.


Subject(s)
Oryza , Solanum tuberosum , Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism , Biomass , Demethylation , Humans , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , RNA, Plant/genetics , Solanum tuberosum/genetics
11.
J Ethnopharmacol ; 267: 113537, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33137430

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Aristolochic acid nephropathy (AAN) is a kidney disease caused by the administration of plants containing aristolochic acids (AAs). Aristolochic acid I (AAI) is the main toxic component in AAs. Organic anion transporters (OATs) 1 and 3 mediate the renal uptake of AAI, which is related to AAN. In our previous study, we found that anthraquinones derived from the herbal medicine Rheum palmatum L. (RP) inhibited both OAT1 and OAT3, with rhein exhibiting the greatest potency among the components. AIM OF THE STUDY: This study aimed to investigate the effects of rhein and RP extract on the pharmacokinetics and tissue distribution of AAI and its demethylated metabolite (8-hydroxy-aristolochic acid I [AAIa]) in rats. MATERIALS AND METHODS: Rhein and RP extract were used as OAT inhibitors, and AAI was used as the toxic substrate. The pharmacokinetics and tissue distribution of AAI and AAIa in rats following the intravenous injection of AAI (10 mg/kg) in the presence and absence of rhein (100 mg/kg) or RP extract (5 g crude drug/kg) were investigated. RESULTS: Co-administration with rhein increased AUC0-∞ of AAI and AAIa by 39 and 44%, respectively. However, the renal level of AAI was decreased to 50, 42, and 58% of those in rats treated with AAI alone at 5, 10, and 20 min after treatment, respectively, and the renal level of AAIa was decreased to 58, 57, and 61% of the level in rats treated with AAI alone, respectively, at these time points. In the RP extract co-administration group, AAI and AAIa plasma exposure was not significantly increased, but renal accumulation of AAI was decreased to 63, 58, and 68% of that in rats treated with AAI alone at 5, 10, and 20 min after treatment, respectively. In addition, renal accumulation of AAIa was decreased to 74, 70, and 70% of that in rats treated with AAI alone at 5, 10, and 20 min after treatment, respectively. CONCLUSIONS: This study indicated that co-administration with rhein significantly increased the plasma exposure of AAI and AAIa while decreased their renal accumulation in rats. RP extract reduced the renal accumulation of AAI and AAIa, but have no significant effect on their plasma exposure levels in rats.


Subject(s)
Anthraquinones/pharmacology , Aristolochic Acids/pharmacokinetics , Organic Anion Transport Protein 1/antagonists & inhibitors , Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors , Plant Extracts/pharmacology , Rheum , Animals , Anthraquinones/isolation & purification , Aristolochic Acids/administration & dosage , Aristolochic Acids/blood , Aristolochic Acids/toxicity , Biotransformation , Demethylation , Injections, Intravenous , Kidney/metabolism , Kidney Diseases/chemically induced , Kidney Diseases/metabolism , Kidney Diseases/prevention & control , Male , Organic Anion Transport Protein 1/metabolism , Organic Anion Transporters, Sodium-Independent/metabolism , Plant Extracts/isolation & purification , Rats, Sprague-Dawley , Rheum/chemistry , Tissue Distribution
12.
Lasers Med Sci ; 35(2): 299-306, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31494789

ABSTRACT

Differentiation potential of stem cells into various lineages makes these cells as promising sources to treat multiple diseases. In this regard, the use of different strategies and protocols to increase differentiation capacity is highly demanded. Low-level laser therapy, a relatively noninvasive technique, has the capacity to accelerate the healing of numerous injuries and a portion of restorative capacity could be correlated with the stem cell activation and differentiation. Several mechanisms have been diagnosed to participate in orientation of stem cells to functional mature cells. Among them, the status of DNA methylation orchestrates the maintenance of tissue-specific gene expression during the differentiation procedure. DNA methylation is a momentous event in embryogenesis and functional maturation. This review article highlighted the potency of laser irradiation (low-level intensities) in the differentiation of stem cells by modulation of methylation. The analysis of these modalities could help us to understand the underlying mechanisms participating in the therapeutic effects of photobiomodulation.


Subject(s)
Cell Differentiation/radiation effects , Epigenesis, Genetic/radiation effects , Low-Level Light Therapy , Stem Cells/cytology , Stem Cells/radiation effects , Animals , DNA Methylation/genetics , DNA Methylation/radiation effects , Demethylation/radiation effects , Humans , Stem Cells/metabolism
13.
Food Funct ; 10(9): 5707-5717, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31436765

ABSTRACT

Polymethoxyflavones (PMFs) are found almost exclusively in citrus peel and have attracted much attention due to their potential health benefits. Dried citrus peel is an important ingredient for applications in food and traditional Chinese medicine. However, the structural changes of PMFs during drying processes of citrus peel remain unknown. In this study, for the first time we discovered that four major permethoxylated PMFs, i.e. sinensetin, nobiletin, heptamethoxyflavone and tangeretin, underwent demethylation at the 5-position on the A ring of their flavonoid structures to yield corresponding 5-demethylated PMFs during the drying process of citrus peel. Our results further demonstrated that the aforementioned PMF demethylation was through two mechanisms: acid hydrolysis and enzyme-mediated catalysis. PMF demethylation in citrus peels was systematically characterized during hot-air drying (HAD), vacuum-freeze drying (VFD) and sun drying (SD). The highest PMF demethylation was obtained in SD followed by HAD and VFD. This study provided a solid scientific basis for rational control of PMF demethylation in citrus peels, which could facilitate the production of high-quality citrus peel and related products.


Subject(s)
Citrus/chemistry , Flavones/chemistry , Plant Extracts/chemistry , Demethylation , Desiccation , Flavonoids/chemistry , Food Handling , Fruit/chemistry
14.
Chembiochem ; 20(9): 1133-1138, 2019 05 02.
Article in English | MEDLINE | ID: mdl-30618116

ABSTRACT

Histone demethylases play a critical role in mammalian gene expression by removing methyl groups from lysine residues in degree- and site-specific manner. To specifically interrogate members and isoforms of this class of enzymes, we have developed demethylase variants with an expanded active site. The mutant enzymes are capable of performing lysine demethylation with wild-type proficiency, but are sensitive to inhibition by cofactor-competitive molecules embellished with a complementary steric "bump". The selected inhibitors show more than 20-fold selectivity over the wild-type demethylase, thus overcoming issues typical to pharmacological and genetic approaches. The mutant-inhibitor pairs are shown to act on a physiologically relevant full-length substrate. By engineering a conserved amino acid to achieve member-specific perturbation, this study provides a general approach for studying histone demethylases in diverse cellular processes.


Subject(s)
Enzyme Inhibitors/chemistry , Jumonji Domain-Containing Histone Demethylases/antagonists & inhibitors , Amino Acids/chemistry , Biocatalysis , Catalytic Domain/genetics , Demethylation , Histones/chemistry , Humans , Jumonji Domain-Containing Histone Demethylases/chemistry , Jumonji Domain-Containing Histone Demethylases/genetics , Molecular Structure , Mutation , Oxalates/chemistry , Protein Engineering/methods , Substrate Specificity
15.
Chin J Integr Med ; 25(5): 354-359, 2019 May.
Article in English | MEDLINE | ID: mdl-29500545

ABSTRACT

OBJECTIVE: To explore the effect of Qinghuang Powder (QHP,()combined with Bupi Yishen Decoction (BPYS, ) on myelodysplastic syndromes (MDS) patients with refractory cytopenia with multilineage dysplasia (RCMD) and determine the change of DNA methylation in MDS-RCMD patients after the treatment of Chinese medicine formula. METHODS: All 308 MDS-RCMD patients were treated with QHP combined with BPYS for 2 months at least, absolute neutrophil count (ANC), hemoglobin (Hb), platelets (PLT), primitive bone marrow cells and chromosome karyotype were chosen as the main evaluation indexes to analyze the treatment effect according to criteria from the MDS International Working Group. Then 43 bone marrow samples from 15 MDS-RCMD patients and 28 healthy donors were obtained for the examination of DNA methylation. Gene Ontology (GO) and Pathway analysis were applied to analyze the methylation data. RESULTS: The overall MDS response rate to QHP was 61.68% (190/360) including hematologic improvement-neutrophil (HI-N) or hematologic improvement-erythroid (HI-E) or hematologic improvement-platelet (HI-P). Patients with anemia had a better response rate than patients with neutropenia or thrombocypenia (55.88% vs 31.54% or 55.88% vs. 36.9%). The DNA methylation microarray analysis disclosed that 4,257 hypermethylated genes were demethylated upon the treatment with QHP and BPYS. GO analysis and Pathway analysis showed that these demethylated genes were involved in a lot of tumor-related pathways and functions. CONCLUSIONS: QHP combined with BPYS could effectively treat MDS-RCMD patients through hematologic improvement (HI-N, HI-P or HI-E) and PLT and RBC transfusion independence due to the demethylation, thereby providing another choice for the treatment of patients with MDS-RCMD.


Subject(s)
Arsenicals/therapeutic use , Cell Lineage , DNA Methylation/drug effects , Drugs, Chinese Herbal/therapeutic use , Leukocyte Disorders/drug therapy , Leukocyte Disorders/genetics , Arsenicals/administration & dosage , Arsenicals/pharmacology , Cell Lineage/drug effects , Demethylation , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/pharmacology , Female , Gene Ontology , Humans , Male , Middle Aged , Powders , Treatment Outcome
16.
J Cell Biochem ; 120(1): 809-820, 2019 01.
Article in English | MEDLINE | ID: mdl-30145810

ABSTRACT

Curcumin, the active component of the spice turmeric, induce global DNA hypomethylation as it has been shown to inhibit DNA methyltransferases. It promotes cell death in cancer cells by arresting in the G1 phase. It was explained to cause increased expression of cell cycle regulator, p21 (WAF1/Cip1); however, the mechanism remains not clear. The p21 promoter harvests a CpG island (CGI) in the proximal region enriched with CG dinucleotide clusters with Kruppel-like factor 4 (KLF4) transcription factor binding site. We probed the p21 promoter CGI (spanning from -135 to +12, respective to the transcription start site) to detect alterations in cytosine methylation level in response to curcumin exposure in four different human cancer cell lines: A431, A549, MCF7, and HeLa. We observed curcumin (20 µM) treatment significantly increased the expression of p21, and the promoter CGI was demethylated in a dose-dependent manner. The curcumin significantly raised the level KLF4 and enhanced the p21 promoter occupancy by KLF4. From our results we hypothesize that curcumin-mediated demethylation of the p21 proximal promoter and increased KLF4 expression as well as its binding to its proximal promoter could serve as a mechanism that could be hypothesized to cause upregulation of p21 in presence of curcumin and thus its therapeutic implications could further be investigated.


Subject(s)
CpG Islands/drug effects , Curcumin/pharmacology , Cyclin-Dependent Kinase Inhibitor p21/genetics , DNA Methylation/drug effects , Demethylation/drug effects , Kruppel-Like Transcription Factors/metabolism , Plant Extracts/pharmacology , Promoter Regions, Genetic/drug effects , A549 Cells , Binding Sites , Cell Survival/drug effects , Curcuma/chemistry , DNA (Cytosine-5-)-Methyltransferase 1/antagonists & inhibitors , HeLa Cells , Humans , Kruppel-Like Factor 4 , MCF-7 Cells , Signal Transduction/drug effects , Tumor Suppressor Protein p53/metabolism
17.
Article in English | WPRIM | ID: wpr-771429

ABSTRACT

OBJECTIVE@#To explore the effect of Qinghuang Powder (QHP,()combined with Bupi Yishen Decoction (BPYS, ) on myelodysplastic syndromes (MDS) patients with refractory cytopenia with multilineage dysplasia (RCMD) and determine the change of DNA methylation in MDS-RCMD patients after the treatment of Chinese medicine formula.@*METHODS@#All 308 MDS-RCMD patients were treated with QHP combined with BPYS for 2 months at least, absolute neutrophil count (ANC), hemoglobin (Hb), platelets (PLT), primitive bone marrow cells and chromosome karyotype were chosen as the main evaluation indexes to analyze the treatment effect according to criteria from the MDS International Working Group. Then 43 bone marrow samples from 15 MDS-RCMD patients and 28 healthy donors were obtained for the examination of DNA methylation. Gene Ontology (GO) and Pathway analysis were applied to analyze the methylation data.@*RESULTS@#The overall MDS response rate to QHP was 61.68% (190/360) including hematologic improvement-neutrophil (HI-N) or hematologic improvement-erythroid (HI-E) or hematologic improvement-platelet (HI-P). Patients with anemia had a better response rate than patients with neutropenia or thrombocypenia (55.88% vs 31.54% or 55.88% vs. 36.9%). The DNA methylation microarray analysis disclosed that 4,257 hypermethylated genes were demethylated upon the treatment with QHP and BPYS. GO analysis and Pathway analysis showed that these demethylated genes were involved in a lot of tumor-related pathways and functions.@*CONCLUSIONS@#QHP combined with BPYS could effectively treat MDS-RCMD patients through hematologic improvement (HI-N, HI-P or HI-E) and PLT and RBC transfusion independence due to the demethylation, thereby providing another choice for the treatment of patients with MDS-RCMD.


Subject(s)
Female , Humans , Male , Middle Aged , Arsenicals , Pharmacology , Therapeutic Uses , Cell Lineage , DNA Methylation , Demethylation , Drugs, Chinese Herbal , Pharmacology , Therapeutic Uses , Gene Ontology , Leukocyte Disorders , Drug Therapy , Genetics , Powders , Treatment Outcome
18.
Planta Med ; 84(5): 320-328, 2018 Mar.
Article in English | MEDLINE | ID: mdl-28950382

ABSTRACT

Scoparone is a natural bioactive compound in Chinese herbal medicines. It has numerous pharmacological actions, including liver protective, hypolipidemic, antitumor, and anti-inflammatory effects. The primary metabolism route of scoparone is O-demethylation to scopoletin or isoscopoletin catalyzed by CYP enzymes. The aims of our study were to identify the human CYP enzymes catalyzing scoparone 7-O-demethylation to scopoletin and to compare this oxidation reaction in liver microsomes among different species. A high throughput fluorescent-based assay method was developed to determine the scoparone 7-O-demethylation to scopoletin rate. The rate was 100 - 400 nmol/(min×g protein) in mouse and rabbit liver microsomes, 10 - 20 nmol/(min×g protein) in pig microsomes, 1 - 3 nmol/(min×g protein) in human and less than 1 nmol/(min×g protein) in rat liver microsomes. Human CYP1A1 (Km 13 µM and Vmax 0.8 min-1), CYP1A2 (Km 48 µM and Vmax 0.3 min-1), and CYP2A13 (Km 10 µM and Vmax 22 min-1) were the most efficient catalysts of the reaction. The CYP2A6 selective inhibitor pilocarpine and an antibody against mouse CYP2A5 inhibited scoparone 7-O-demethylation to scopoletin in rabbit, mouse, and pig liver microsomes, indicating involvement of CYP2A enzymes in the reaction. Hepatic scoparone 7-O-demethylation to scopoletin differed between species both with respect to the rate of reaction and catalyzing enzymes. These species differences need to be taken into account when testing scoparone pharmacokinetics in animals and humans.


Subject(s)
Coumarins/metabolism , Cytochrome P-450 Enzyme System/metabolism , Scopoletin/analogs & derivatives , Scopoletin/metabolism , Animals , Aryl Hydrocarbon Hydroxylases/metabolism , Coumarins/chemistry , Cytochrome P-450 CYP1A1/metabolism , Cytochrome P-450 CYP1A2/metabolism , Demethylation , Female , Humans , Male , Mice , Microsomes, Liver/enzymology , Molecular Structure , Oxidation-Reduction , Rabbits , Rats , Scopoletin/chemistry , Swine
19.
J Allergy Clin Immunol ; 141(2): 659-670.e2, 2018 02.
Article in English | MEDLINE | ID: mdl-28479331

ABSTRACT

BACKGROUND: Regulatory T (Treg) cells play an essential role in the maintenance of immune homeostasis in allergic diseases. OBJECTIVES: We sought to define the mechanisms underlying induction of tolerance to peanut protein and prevention of the development of peanut allergy. METHODS: High or low doses of peanut extract were administered to pups every day for 2 weeks before peanut sensitization and challenge. After challenge, symptoms, Treg cell numbers, and forkhead box protein 3 (Foxp3), TH2 and TH17 cytokine, and Tgfß expression in mesenteric lymph node (MLN) CD4+ T cells and jejunum were monitored. Treg cell suppressive activity and Foxp3 methylation in MLN CD4+ T cells were assayed. RESULTS: Feeding high but not low doses of peanut before sensitization induced tolerance, as demonstrated by prevention of diarrhea and peanut-specific IgE responses, increases in the percentage of CD4+CD25+FoxP3+ cells in MLNs, and Foxp3 mRNA and protein expression in CD4+ cells from MLNs or jejunum. Feeding high doses of peanut before sensitization decreased percentages of CD3+CD4+IL-13+ and CD3+CD4+IL-17+ cells in MLNs and decreased Il13 and Il17a and increased Tgfß mRNA expression in the jejunum; numbers of CD103+ dendritic cells in MLNs were significantly increased. Treg cell suppression was shown to be antigen specific. Foxp3 methylation was increased in peanut extract-sensitized and challenged mice, whereas in tolerized mice levels were significantly reduced. CONCLUSIONS: Feeding high doses of peanut to pups induced tolerance to peanut protein. Foxp3 demethylation was associated with tolerance induction, indicating that Treg cells play an important role in the regulation of peanut sensitivity and maintenance of immune homeostasis.


Subject(s)
Arachis/chemistry , Forkhead Transcription Factors/immunology , Immune Tolerance/drug effects , Jejunum/immunology , Peanut Hypersensitivity , Plant Extracts/pharmacology , T-Lymphocytes, Helper-Inducer/immunology , Animals , Cytokines/immunology , Demethylation/drug effects , Disease Models, Animal , Jejunum/pathology , Mice , Mice, Inbred BALB C , Peanut Hypersensitivity/immunology , Peanut Hypersensitivity/pathology , Peanut Hypersensitivity/prevention & control , Plant Extracts/chemistry , Plant Extracts/immunology , T-Lymphocytes, Helper-Inducer/pathology
20.
Environ Pollut ; 231(Pt 2): 1543-1551, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28928020

ABSTRACT

The antagonistic effect of selenium (Se) on mercury (Hg) toxicity has been known for decades. Earlier studies mainly focused on Hg-Se interaction based on biokinetics and bioaccumulation, but the influences of Se on in vivo biotransformation of methylmercury (MeHg) have not been well understood. We conducted a 42-day exposure study to investigate the dynamic changes of MeHg and its primary degradation product - inorganic mercury (IHg) - in different organs of black seabream (Acanthopagrus schlegeli) exposed to different dietary Se levels. A physiologically based pharmacokinetic (PBPK) model was then developed to describe the biotransformation and disposition of MeHg under the influence of Se. Our results demonstrated that Se significantly increased the transformation from MeHg into IHg, thereby decreasing the accumulation of MeHg. The simulation further showed that the intestine was the major site for demethylation, with an estimated rate 1.5-fold higher in high Se treatment than in low Se treatment. However, the hepatic demethylation rate was extremely low and comparable between the two treatments (0.012-0.015 d-1). These results strongly suggested that the intestine instead of the commonly assumed liver was the major site for Hg-Se interaction. Furthermore, Se did not show significant influences on the distribution and elimination of MeHg, but promoted the uptake and elimination of the generated IHg from demethylation. Therefore, Se-induced demethylation especially in the intestine played an important role in mitigating the MeHg accumulation. This study provided new sight to elucidate the Hg-Se interaction in fish.


Subject(s)
Methylmercury Compounds/metabolism , Perciformes/metabolism , Selenium/metabolism , Water Pollutants, Chemical/metabolism , Animals , Biological Transport , Biotransformation , Demethylation , Dose-Response Relationship, Drug , Drug Interactions , Kinetics , Liver/metabolism , Methylmercury Compounds/analysis , Models, Biological , Organ Specificity , Selenium/analysis , Tissue Distribution , Water Pollutants, Chemical/analysis
SELECTION OF CITATIONS
SEARCH DETAIL